ArticleDiabetes, obesity & metabolism2026

GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study.

Jisu Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.